Wednesday, February 27, 2008

Valganciclovir: Ranbaxy files post grant opposition

Mint reports that Ranbaxy has filed a post-grant opposition to the Valganciclovir product patent [IN207232].

Cipla which had earlier stated that it would lodge in a post grant opposition has. as yet, not done so.

This news was posted on the genericIP blog, but I missed putting it here.

No comments: